![Patricia Snyder-Johnson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Patricia Snyder-Johnson
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Pharmasset, Inc.
![]() Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ.
4
| Subsidiary | Pharmaceuticals: Other | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Patricia Snyder-Johnson via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arbutus Biopharma, Inc.
![]() Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
IVERIC BIO, INC. | Pharmaceuticals: Generic | Chief Operating Officer | |
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Corporate Officer/Principal | |
Drexel University | College/University | Graduate Degree | |
State University of New York College at Geneseo | College/University | Undergraduate Degree | |
Columbia Business School | College/University | Masters Business Admin | |
Roivant Sciences GmbH
![]() Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Campbell University | College/University | Doctorate Degree | |
ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Altavant Sciences, Inc.
![]() Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
Enzyvant, Inc.
![]() Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer | |
CHIASMA, INC. | Pharmaceuticals: Major | Chairman | |
Pfizer Pharmaceuticals, Inc.
![]() Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Emory University | College/University | Graduate Degree | |
OCEAN BIOMEDICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
CHIMERIX, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
The North Carolina Biotechnology Center
![]() The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member | |
Noveome Biotherapeutics, Inc.
![]() Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Biotechnology | Director/Board Member | |
Ocean Biomedical, Inc. (United States)
![]() Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Miscellaneous Commercial Services | Director/Board Member | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Georgia Health Sciences University | College/University | Doctorate Degree | |
Virion Therapeutics LLC
![]() Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Biotechnology | Director/Board Member | |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Chairman | |
Glycadia, Inc.
![]() Glycadia, Inc. Pharmaceuticals: MajorHealth Technology Glycadia, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics for the prevention and treatment of kidney, eye, cardiovascular, and related diseases resulting from diabetes. The private company is based in Philadelphia, PA, and has subsidiaries in the United States. The company's science is based on recent discoveries concerning the causal role of circulating glycated. Glycadia's experienced R&D team is bringing new scientific discoveries to clinical trials of innovative products for complications of diabetes, including nephropathy, retinopathy, and cardiovascular disease. | Pharmaceuticals: Major | Chairman | |
OMRIX Biopharmaceuticals, Inc.
![]() OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Chairman | |
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Executive Officer | |
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
RxFDP | Founder | ||
Dartmouth College | College/University | Undergraduate Degree | |
Enzyvant Therapeutics GmbH
![]() Enzyvant Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Enzyvant Therapeutics GmbH is a Swiss biotechnology company that focuses on developing treatments for rare diseases. The company is based in Basel, Switzerland. William T. Symonds has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 34 |
Verenigd Koninkrijk | 3 |
Zwitserland | 3 |
Israël | 2 |
Denemarken | 2 |
Sectoraal
Health Technology | 28 |
Consumer Services | 9 |
Commercial Services | 4 |
Technology Services | 2 |
Operationeel
Director/Board Member | 12 |
Corporate Officer/Principal | 12 |
Chief Executive Officer | 7 |
Chairman | 7 |
Chief Tech/Sci/R&D Officer | 3 |
Sterkste connecties
Insiders | |
---|---|
Fredric D. Price | 16 |
M. Berrey | 11 |
William T. Symonds | 11 |
Keith Westby | 6 |
- Beurs
- Insiders
- Patricia Snyder-Johnson
- Bedrijfsconnecties